Learn more

AVESTHAGEN LTD

Overview
  • Total Patents
    117
  • GoodIP Patent Rank
    237,567
About

AVESTHAGEN LTD has a total of 117 patent applications. Its first patent ever was published in 2003. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are SANGAMO BIOSCIENCES INC, VENTRIA BIOSCIENCE and ROSSOMANDO ANTHONY.

Patent filings per year

Chart showing AVESTHAGEN LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Patell Villoo Morawala 58
#2 Sadasivam Suresh 19
#3 Ramakrishna Manjula 18
#4 Shekar Sunil 17
#5 Venkataramaiah Mahesh 17
#6 Maity Sunit 16
#7 Patell Villoo Morawal 14
#8 Jain Renuka 14
#9 Nimbalkar Suhas 13
#10 Ullanat Rajesh 13

Latest patents

Publication Filing date Title
WO2011058423A2 Identification and characterization of natural chemical entities by liquid chromatography and mass spectrometry lc-ms/ms and uses thereof
WO2011024065A1 A method of developing stress tolerant plants exhibiting self-glucogenic properties for use in bioethanol production from lignocellulosic biomass
WO2011015924A2 Vectors and compounds for expression of recombinant trastuzumab
WO2011015926A1 A process of fermentation, purification and production of recombinant soluble tumour necrosis factor alfa receptor (tnfr) - human igg fc fusion protein
WO2011015916A2 Vectors and compounds for expression of recombinant infliximab
WO2011015918A2 Vectors and compounds for expression of recombinant cetuximab
WO2011015922A1 A highly efficient process of purification and production of recombinant tnk-tpa (tenecteplase)
WO2011015921A1 A highly efficient process of purification and production of recombinant cetuximab
WO2011015917A2 Vectors and compounds for expression of recombinant tnk-tpa (tenecteplase)
WO2011015920A2 A highly efficient process of purification and production of recombinant trastuzumab
WO2011015919A1 A highly efficient process of purification and production of recombinant infliximab
WO2010122405A2 A method for over expression of chemical constituents in plants
WO2011070405A1 An expression vector carrying scaffold/matrix attachment region(s)
CN102246030A A method of characterizing phytochemicals from trigonella foenum graceum
AP201105739A0 An expression vector and processes thereof.
WO2011024025A1 An erythropoietin analogue and a method thereof
WO2011024024A1 A process for recovering darbepoeitin alfa isoforms
BRPI0918008A2 expression vector and method of it
CN102177242A Change in plant architecture
CA2734276A1 Glutamate decarboxylase (gad) transgenic plants with enhanced nitrogen uptake and utilisation